Movement Disorders (revue)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Botulinum toxin type A therapy during pregnancy

Identifieur interne : 002024 ( PascalFrancis/Corpus ); précédent : 002023; suivant : 002025

Botulinum toxin type A therapy during pregnancy

Auteurs : William J. Newman ; Thomas L. Davis ; Bismal B. Padaliya ; Cassondra D. Covington ; Chandler E. Gill ; Anna I. Ahramovitch ; P. David Charles

Source :

RBID : Pascal:05-0001177

Descripteurs français

English descriptors

Abstract

Injection with botulinum toxin type A (Botox) is a safe and efficacious treatment for idiopathic cervical dystonia. We present the first case report of clinical Botox treatment during pregnancy. This patient underwent four apparently uncomplicated full-term pregnancies while receiving regular Botox treatments.

Notice en format standard (ISO 2709)

Pour connaître la documentation sur le format Inist Standard.

pA  
A01 01  1    @0 0885-3185
A03   1    @0 Mov. disord.
A05       @2 19
A06       @2 11
A08 01  1  ENG  @1 Botulinum toxin type A therapy during pregnancy
A11 01  1    @1 NEWMAN (William J.)
A11 02  1    @1 DAVIS (Thomas L.)
A11 03  1    @1 PADALIYA (Bismal B.)
A11 04  1    @1 COVINGTON (Cassondra D.)
A11 05  1    @1 GILL (Chandler E.)
A11 06  1    @1 AHRAMOVITCH (Anna I.)
A11 07  1    @1 CHARLES (P. David)
A14 01      @1 School of Medicine, Vanderbilt University Medical Center @2 Nashville, Tennessee @3 USA @Z 1 aut. @Z 3 aut. @Z 6 aut.
A14 02      @1 Division of Movement Disorders, Department of Neurology, Vanderbilt University Medical Center @2 Nashville, Tennessee @3 USA @Z 2 aut. @Z 4 aut. @Z 5 aut. @Z 7 aut.
A20       @1 1384-1385
A21       @1 2004
A23 01      @0 ENG
A43 01      @1 INIST @2 20953 @5 354000122631260240
A44       @0 0000 @1 © 2005 INIST-CNRS. All rights reserved.
A45       @0 7 ref.
A47 01  1    @0 05-0001177
A60       @1 P
A61       @0 A
A64 01  1    @0 Movement disorders
A66 01      @0 USA
C01 01    ENG  @0 Injection with botulinum toxin type A (Botox) is a safe and efficacious treatment for idiopathic cervical dystonia. We present the first case report of clinical Botox treatment during pregnancy. This patient underwent four apparently uncomplicated full-term pregnancies while receiving regular Botox treatments.
C02 01  X    @0 002B17
C02 02  X    @0 002B02C
C02 03  X    @0 002B02Q
C03 01  X  FRE  @0 Système nerveux pathologie @5 01
C03 01  X  ENG  @0 Nervous system diseases @5 01
C03 01  X  SPA  @0 Sistema nervioso patología @5 01
C03 02  X  FRE  @0 Bontoxilysin @2 FE @2 FR @5 02
C03 02  X  ENG  @0 Bontoxilysin @2 FE @2 FR @5 02
C03 02  X  SPA  @0 Bontoxilysin @2 FE @2 FR @5 02
C03 03  X  FRE  @0 Traitement @5 03
C03 03  X  ENG  @0 Treatment @5 03
C03 03  X  SPA  @0 Tratamiento @5 03
C03 04  X  FRE  @0 Gestation @5 05
C03 04  X  ENG  @0 Pregnancy @5 05
C03 04  X  SPA  @0 Gestación @5 05
C07 01  X  FRE  @0 Metalloendopeptidases @2 FE
C07 01  X  ENG  @0 Metalloendopeptidases @2 FE
C07 01  X  SPA  @0 Metalloendopeptidases @2 FE
C07 02  X  FRE  @0 Peptidases @2 FE
C07 02  X  ENG  @0 Peptidases @2 FE
C07 02  X  SPA  @0 Peptidases @2 FE
C07 03  X  FRE  @0 Hydrolases @2 FE
C07 03  X  ENG  @0 Hydrolases @2 FE
C07 03  X  SPA  @0 Hydrolases @2 FE
C07 04  X  FRE  @0 Enzyme @2 FE
C07 04  X  ENG  @0 Enzyme @2 FE
C07 04  X  SPA  @0 Enzima @2 FE
N21       @1 004
N44 01      @1 OTO
N82       @1 OTO

Format Inist (serveur)

NO : PASCAL 05-0001177 INIST
ET : Botulinum toxin type A therapy during pregnancy
AU : NEWMAN (William J.); DAVIS (Thomas L.); PADALIYA (Bismal B.); COVINGTON (Cassondra D.); GILL (Chandler E.); AHRAMOVITCH (Anna I.); CHARLES (P. David)
AF : School of Medicine, Vanderbilt University Medical Center/Nashville, Tennessee/Etats-Unis (1 aut., 3 aut., 6 aut.); Division of Movement Disorders, Department of Neurology, Vanderbilt University Medical Center/Nashville, Tennessee/Etats-Unis (2 aut., 4 aut., 5 aut., 7 aut.)
DT : Publication en série; Niveau analytique
SO : Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 2004; Vol. 19; No. 11; Pp. 1384-1385; Bibl. 7 ref.
LA : Anglais
EA : Injection with botulinum toxin type A (Botox) is a safe and efficacious treatment for idiopathic cervical dystonia. We present the first case report of clinical Botox treatment during pregnancy. This patient underwent four apparently uncomplicated full-term pregnancies while receiving regular Botox treatments.
CC : 002B17; 002B02C; 002B02Q
FD : Système nerveux pathologie; Bontoxilysin; Traitement; Gestation
FG : Metalloendopeptidases; Peptidases; Hydrolases; Enzyme
ED : Nervous system diseases; Bontoxilysin; Treatment; Pregnancy
EG : Metalloendopeptidases; Peptidases; Hydrolases; Enzyme
SD : Sistema nervioso patología; Bontoxilysin; Tratamiento; Gestación
LO : INIST-20953.354000122631260240
ID : 05-0001177

Links to Exploration step

Pascal:05-0001177

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="a">Botulinum toxin type A therapy during pregnancy</title>
<author>
<name sortKey="Newman, William J" sort="Newman, William J" uniqKey="Newman W" first="William J." last="Newman">William J. Newman</name>
<affiliation>
<inist:fA14 i1="01">
<s1>School of Medicine, Vanderbilt University Medical Center</s1>
<s2>Nashville, Tennessee</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Davis, Thomas L" sort="Davis, Thomas L" uniqKey="Davis T" first="Thomas L." last="Davis">Thomas L. Davis</name>
<affiliation>
<inist:fA14 i1="02">
<s1>Division of Movement Disorders, Department of Neurology, Vanderbilt University Medical Center</s1>
<s2>Nashville, Tennessee</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Padaliya, Bismal B" sort="Padaliya, Bismal B" uniqKey="Padaliya B" first="Bismal B." last="Padaliya">Bismal B. Padaliya</name>
<affiliation>
<inist:fA14 i1="01">
<s1>School of Medicine, Vanderbilt University Medical Center</s1>
<s2>Nashville, Tennessee</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Covington, Cassondra D" sort="Covington, Cassondra D" uniqKey="Covington C" first="Cassondra D." last="Covington">Cassondra D. Covington</name>
<affiliation>
<inist:fA14 i1="02">
<s1>Division of Movement Disorders, Department of Neurology, Vanderbilt University Medical Center</s1>
<s2>Nashville, Tennessee</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Gill, Chandler E" sort="Gill, Chandler E" uniqKey="Gill C" first="Chandler E." last="Gill">Chandler E. Gill</name>
<affiliation>
<inist:fA14 i1="02">
<s1>Division of Movement Disorders, Department of Neurology, Vanderbilt University Medical Center</s1>
<s2>Nashville, Tennessee</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Ahramovitch, Anna I" sort="Ahramovitch, Anna I" uniqKey="Ahramovitch A" first="Anna I." last="Ahramovitch">Anna I. Ahramovitch</name>
<affiliation>
<inist:fA14 i1="01">
<s1>School of Medicine, Vanderbilt University Medical Center</s1>
<s2>Nashville, Tennessee</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Charles, P David" sort="Charles, P David" uniqKey="Charles P" first="P. David" last="Charles">P. David Charles</name>
<affiliation>
<inist:fA14 i1="02">
<s1>Division of Movement Disorders, Department of Neurology, Vanderbilt University Medical Center</s1>
<s2>Nashville, Tennessee</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">INIST</idno>
<idno type="inist">05-0001177</idno>
<date when="2004">2004</date>
<idno type="stanalyst">PASCAL 05-0001177 INIST</idno>
<idno type="RBID">Pascal:05-0001177</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">002024</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a">Botulinum toxin type A therapy during pregnancy</title>
<author>
<name sortKey="Newman, William J" sort="Newman, William J" uniqKey="Newman W" first="William J." last="Newman">William J. Newman</name>
<affiliation>
<inist:fA14 i1="01">
<s1>School of Medicine, Vanderbilt University Medical Center</s1>
<s2>Nashville, Tennessee</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Davis, Thomas L" sort="Davis, Thomas L" uniqKey="Davis T" first="Thomas L." last="Davis">Thomas L. Davis</name>
<affiliation>
<inist:fA14 i1="02">
<s1>Division of Movement Disorders, Department of Neurology, Vanderbilt University Medical Center</s1>
<s2>Nashville, Tennessee</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Padaliya, Bismal B" sort="Padaliya, Bismal B" uniqKey="Padaliya B" first="Bismal B." last="Padaliya">Bismal B. Padaliya</name>
<affiliation>
<inist:fA14 i1="01">
<s1>School of Medicine, Vanderbilt University Medical Center</s1>
<s2>Nashville, Tennessee</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Covington, Cassondra D" sort="Covington, Cassondra D" uniqKey="Covington C" first="Cassondra D." last="Covington">Cassondra D. Covington</name>
<affiliation>
<inist:fA14 i1="02">
<s1>Division of Movement Disorders, Department of Neurology, Vanderbilt University Medical Center</s1>
<s2>Nashville, Tennessee</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Gill, Chandler E" sort="Gill, Chandler E" uniqKey="Gill C" first="Chandler E." last="Gill">Chandler E. Gill</name>
<affiliation>
<inist:fA14 i1="02">
<s1>Division of Movement Disorders, Department of Neurology, Vanderbilt University Medical Center</s1>
<s2>Nashville, Tennessee</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Ahramovitch, Anna I" sort="Ahramovitch, Anna I" uniqKey="Ahramovitch A" first="Anna I." last="Ahramovitch">Anna I. Ahramovitch</name>
<affiliation>
<inist:fA14 i1="01">
<s1>School of Medicine, Vanderbilt University Medical Center</s1>
<s2>Nashville, Tennessee</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Charles, P David" sort="Charles, P David" uniqKey="Charles P" first="P. David" last="Charles">P. David Charles</name>
<affiliation>
<inist:fA14 i1="02">
<s1>Division of Movement Disorders, Department of Neurology, Vanderbilt University Medical Center</s1>
<s2>Nashville, Tennessee</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series>
<title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint>
<date when="2004">2004</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Bontoxilysin</term>
<term>Nervous system diseases</term>
<term>Pregnancy</term>
<term>Treatment</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Système nerveux pathologie</term>
<term>Bontoxilysin</term>
<term>Traitement</term>
<term>Gestation</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Injection with botulinum toxin type A (Botox) is a safe and efficacious treatment for idiopathic cervical dystonia. We present the first case report of clinical Botox treatment during pregnancy. This patient underwent four apparently uncomplicated full-term pregnancies while receiving regular Botox treatments.</div>
</front>
</TEI>
<inist>
<standard h6="B">
<pA>
<fA01 i1="01" i2="1">
<s0>0885-3185</s0>
</fA01>
<fA03 i2="1">
<s0>Mov. disord.</s0>
</fA03>
<fA05>
<s2>19</s2>
</fA05>
<fA06>
<s2>11</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG">
<s1>Botulinum toxin type A therapy during pregnancy</s1>
</fA08>
<fA11 i1="01" i2="1">
<s1>NEWMAN (William J.)</s1>
</fA11>
<fA11 i1="02" i2="1">
<s1>DAVIS (Thomas L.)</s1>
</fA11>
<fA11 i1="03" i2="1">
<s1>PADALIYA (Bismal B.)</s1>
</fA11>
<fA11 i1="04" i2="1">
<s1>COVINGTON (Cassondra D.)</s1>
</fA11>
<fA11 i1="05" i2="1">
<s1>GILL (Chandler E.)</s1>
</fA11>
<fA11 i1="06" i2="1">
<s1>AHRAMOVITCH (Anna I.)</s1>
</fA11>
<fA11 i1="07" i2="1">
<s1>CHARLES (P. David)</s1>
</fA11>
<fA14 i1="01">
<s1>School of Medicine, Vanderbilt University Medical Center</s1>
<s2>Nashville, Tennessee</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>6 aut.</sZ>
</fA14>
<fA14 i1="02">
<s1>Division of Movement Disorders, Department of Neurology, Vanderbilt University Medical Center</s1>
<s2>Nashville, Tennessee</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
</fA14>
<fA20>
<s1>1384-1385</s1>
</fA20>
<fA21>
<s1>2004</s1>
</fA21>
<fA23 i1="01">
<s0>ENG</s0>
</fA23>
<fA43 i1="01">
<s1>INIST</s1>
<s2>20953</s2>
<s5>354000122631260240</s5>
</fA43>
<fA44>
<s0>0000</s0>
<s1>© 2005 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45>
<s0>7 ref.</s0>
</fA45>
<fA47 i1="01" i2="1">
<s0>05-0001177</s0>
</fA47>
<fA60>
<s1>P</s1>
</fA60>
<fA61>
<s0>A</s0>
</fA61>
<fA64 i1="01" i2="1">
<s0>Movement disorders</s0>
</fA64>
<fA66 i1="01">
<s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG">
<s0>Injection with botulinum toxin type A (Botox) is a safe and efficacious treatment for idiopathic cervical dystonia. We present the first case report of clinical Botox treatment during pregnancy. This patient underwent four apparently uncomplicated full-term pregnancies while receiving regular Botox treatments.</s0>
</fC01>
<fC02 i1="01" i2="X">
<s0>002B17</s0>
</fC02>
<fC02 i1="02" i2="X">
<s0>002B02C</s0>
</fC02>
<fC02 i1="03" i2="X">
<s0>002B02Q</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE">
<s0>Système nerveux pathologie</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG">
<s0>Nervous system diseases</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA">
<s0>Sistema nervioso patología</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE">
<s0>Bontoxilysin</s0>
<s2>FE</s2>
<s2>FR</s2>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG">
<s0>Bontoxilysin</s0>
<s2>FE</s2>
<s2>FR</s2>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA">
<s0>Bontoxilysin</s0>
<s2>FE</s2>
<s2>FR</s2>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE">
<s0>Traitement</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG">
<s0>Treatment</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA">
<s0>Tratamiento</s0>
<s5>03</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE">
<s0>Gestation</s0>
<s5>05</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG">
<s0>Pregnancy</s0>
<s5>05</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA">
<s0>Gestación</s0>
<s5>05</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE">
<s0>Metalloendopeptidases</s0>
<s2>FE</s2>
</fC07>
<fC07 i1="01" i2="X" l="ENG">
<s0>Metalloendopeptidases</s0>
<s2>FE</s2>
</fC07>
<fC07 i1="01" i2="X" l="SPA">
<s0>Metalloendopeptidases</s0>
<s2>FE</s2>
</fC07>
<fC07 i1="02" i2="X" l="FRE">
<s0>Peptidases</s0>
<s2>FE</s2>
</fC07>
<fC07 i1="02" i2="X" l="ENG">
<s0>Peptidases</s0>
<s2>FE</s2>
</fC07>
<fC07 i1="02" i2="X" l="SPA">
<s0>Peptidases</s0>
<s2>FE</s2>
</fC07>
<fC07 i1="03" i2="X" l="FRE">
<s0>Hydrolases</s0>
<s2>FE</s2>
</fC07>
<fC07 i1="03" i2="X" l="ENG">
<s0>Hydrolases</s0>
<s2>FE</s2>
</fC07>
<fC07 i1="03" i2="X" l="SPA">
<s0>Hydrolases</s0>
<s2>FE</s2>
</fC07>
<fC07 i1="04" i2="X" l="FRE">
<s0>Enzyme</s0>
<s2>FE</s2>
</fC07>
<fC07 i1="04" i2="X" l="ENG">
<s0>Enzyme</s0>
<s2>FE</s2>
</fC07>
<fC07 i1="04" i2="X" l="SPA">
<s0>Enzima</s0>
<s2>FE</s2>
</fC07>
<fN21>
<s1>004</s1>
</fN21>
<fN44 i1="01">
<s1>OTO</s1>
</fN44>
<fN82>
<s1>OTO</s1>
</fN82>
</pA>
</standard>
<server>
<NO>PASCAL 05-0001177 INIST</NO>
<ET>Botulinum toxin type A therapy during pregnancy</ET>
<AU>NEWMAN (William J.); DAVIS (Thomas L.); PADALIYA (Bismal B.); COVINGTON (Cassondra D.); GILL (Chandler E.); AHRAMOVITCH (Anna I.); CHARLES (P. David)</AU>
<AF>School of Medicine, Vanderbilt University Medical Center/Nashville, Tennessee/Etats-Unis (1 aut., 3 aut., 6 aut.); Division of Movement Disorders, Department of Neurology, Vanderbilt University Medical Center/Nashville, Tennessee/Etats-Unis (2 aut., 4 aut., 5 aut., 7 aut.)</AF>
<DT>Publication en série; Niveau analytique</DT>
<SO>Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 2004; Vol. 19; No. 11; Pp. 1384-1385; Bibl. 7 ref.</SO>
<LA>Anglais</LA>
<EA>Injection with botulinum toxin type A (Botox) is a safe and efficacious treatment for idiopathic cervical dystonia. We present the first case report of clinical Botox treatment during pregnancy. This patient underwent four apparently uncomplicated full-term pregnancies while receiving regular Botox treatments.</EA>
<CC>002B17; 002B02C; 002B02Q</CC>
<FD>Système nerveux pathologie; Bontoxilysin; Traitement; Gestation</FD>
<FG>Metalloendopeptidases; Peptidases; Hydrolases; Enzyme</FG>
<ED>Nervous system diseases; Bontoxilysin; Treatment; Pregnancy</ED>
<EG>Metalloendopeptidases; Peptidases; Hydrolases; Enzyme</EG>
<SD>Sistema nervioso patología; Bontoxilysin; Tratamiento; Gestación</SD>
<LO>INIST-20953.354000122631260240</LO>
<ID>05-0001177</ID>
</server>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PascalFrancis/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002024 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 002024 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    PascalFrancis
   |étape=   Corpus
   |type=    RBID
   |clé=     Pascal:05-0001177
   |texte=   Botulinum toxin type A therapy during pregnancy
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024